Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed Mar 28, 2025 · 10-K · 87 days after period end · 0001753926-25-000507
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|
| Revenue | $173.67K | $120.84K | $151.01K |
| Net Income | -$1.44M | -$688.88K | -$363.92K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end
